Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells

Wei Hsin Chiu, Helen Hai Wen Chen, Jang Yang Chang, Sheng Jie Luo, Chia Ling Li, Chia Ling Chen, Wu Chou Su, Chiou Feng Lin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The standard treatment regimen for patients diagnosed with non-small cell lung cancer (NSCLC) with locally advanced stage III disease is concurrent chemoradiotherapy (CCRT). This study investigated the molecular effects of vinca alkaloid vinorelbine (VNR)-based CCRT. We reviewed the records of 68 patients with stage III NSCLC: 42 patients received VNR-based CCRT, and 26 were treated with radiation alone. Human lung adenocarcinoma cells were used in this study to investigate the molecular effects of glucosylceramide synthase inhibition on VNR-based CCRT. There was response rate of 66.7% with CCRT, which was better than the response rate observed with radiation alone (30.8%; P2/M phase accompanied by apoptosis. Oxidative c-Jun N-terminal kinase (JNK) activation was involved in the increased apoptosis levels but not the cell cycle arrest. CCRT also induced an increase in ceramide accompanied by a decrease in glucosylceramide that was positively correlated with the cytotoxic effects. Pharmacologically inhibiting glucosylceramide synthase facilitated VNR- and CCRT-induced apoptosis by promoting the JNK pathway. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of VNR by promoting JNK-mediated apoptosis in lung adenocarcinoma cells.

Original languageEnglish
Pages (from-to)144-151
Number of pages8
JournalCancer Letters
Volume349
Issue number2
DOIs
Publication statusPublished - Jul 28 2014
Externally publishedYes

Fingerprint

ceramide glucosyltransferase
Radiation-Sensitizing Agents
Chemoradiotherapy
Apoptosis
Non-Small Cell Lung Carcinoma
Phosphotransferases
Radiation
Vinca Alkaloids
Glucosylceramides
JNK Mitogen-Activated Protein Kinases
Ceramides
Cell Cycle Checkpoints
vinorelbine
Adenocarcinoma of lung
Cell Division

Keywords

  • CCRT
  • Ceramide
  • JNK
  • NSCLC
  • Vinorelbine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells. / Chiu, Wei Hsin; Chen, Helen Hai Wen; Chang, Jang Yang; Luo, Sheng Jie; Li, Chia Ling; Chen, Chia Ling; Su, Wu Chou; Lin, Chiou Feng.

In: Cancer Letters, Vol. 349, No. 2, 28.07.2014, p. 144-151.

Research output: Contribution to journalArticle

Chiu, Wei Hsin ; Chen, Helen Hai Wen ; Chang, Jang Yang ; Luo, Sheng Jie ; Li, Chia Ling ; Chen, Chia Ling ; Su, Wu Chou ; Lin, Chiou Feng. / Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells. In: Cancer Letters. 2014 ; Vol. 349, No. 2. pp. 144-151.
@article{568edde947fd40c5a905f2673fbbd156,
title = "Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells",
abstract = "The standard treatment regimen for patients diagnosed with non-small cell lung cancer (NSCLC) with locally advanced stage III disease is concurrent chemoradiotherapy (CCRT). This study investigated the molecular effects of vinca alkaloid vinorelbine (VNR)-based CCRT. We reviewed the records of 68 patients with stage III NSCLC: 42 patients received VNR-based CCRT, and 26 were treated with radiation alone. Human lung adenocarcinoma cells were used in this study to investigate the molecular effects of glucosylceramide synthase inhibition on VNR-based CCRT. There was response rate of 66.7{\%} with CCRT, which was better than the response rate observed with radiation alone (30.8{\%}; P2/M phase accompanied by apoptosis. Oxidative c-Jun N-terminal kinase (JNK) activation was involved in the increased apoptosis levels but not the cell cycle arrest. CCRT also induced an increase in ceramide accompanied by a decrease in glucosylceramide that was positively correlated with the cytotoxic effects. Pharmacologically inhibiting glucosylceramide synthase facilitated VNR- and CCRT-induced apoptosis by promoting the JNK pathway. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of VNR by promoting JNK-mediated apoptosis in lung adenocarcinoma cells.",
keywords = "CCRT, Ceramide, JNK, NSCLC, Vinorelbine",
author = "Chiu, {Wei Hsin} and Chen, {Helen Hai Wen} and Chang, {Jang Yang} and Luo, {Sheng Jie} and Li, {Chia Ling} and Chen, {Chia Ling} and Su, {Wu Chou} and Lin, {Chiou Feng}",
year = "2014",
month = "7",
day = "28",
doi = "10.1016/j.canlet.2014.04.005",
language = "English",
volume = "349",
pages = "144--151",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells

AU - Chiu, Wei Hsin

AU - Chen, Helen Hai Wen

AU - Chang, Jang Yang

AU - Luo, Sheng Jie

AU - Li, Chia Ling

AU - Chen, Chia Ling

AU - Su, Wu Chou

AU - Lin, Chiou Feng

PY - 2014/7/28

Y1 - 2014/7/28

N2 - The standard treatment regimen for patients diagnosed with non-small cell lung cancer (NSCLC) with locally advanced stage III disease is concurrent chemoradiotherapy (CCRT). This study investigated the molecular effects of vinca alkaloid vinorelbine (VNR)-based CCRT. We reviewed the records of 68 patients with stage III NSCLC: 42 patients received VNR-based CCRT, and 26 were treated with radiation alone. Human lung adenocarcinoma cells were used in this study to investigate the molecular effects of glucosylceramide synthase inhibition on VNR-based CCRT. There was response rate of 66.7% with CCRT, which was better than the response rate observed with radiation alone (30.8%; P2/M phase accompanied by apoptosis. Oxidative c-Jun N-terminal kinase (JNK) activation was involved in the increased apoptosis levels but not the cell cycle arrest. CCRT also induced an increase in ceramide accompanied by a decrease in glucosylceramide that was positively correlated with the cytotoxic effects. Pharmacologically inhibiting glucosylceramide synthase facilitated VNR- and CCRT-induced apoptosis by promoting the JNK pathway. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of VNR by promoting JNK-mediated apoptosis in lung adenocarcinoma cells.

AB - The standard treatment regimen for patients diagnosed with non-small cell lung cancer (NSCLC) with locally advanced stage III disease is concurrent chemoradiotherapy (CCRT). This study investigated the molecular effects of vinca alkaloid vinorelbine (VNR)-based CCRT. We reviewed the records of 68 patients with stage III NSCLC: 42 patients received VNR-based CCRT, and 26 were treated with radiation alone. Human lung adenocarcinoma cells were used in this study to investigate the molecular effects of glucosylceramide synthase inhibition on VNR-based CCRT. There was response rate of 66.7% with CCRT, which was better than the response rate observed with radiation alone (30.8%; P2/M phase accompanied by apoptosis. Oxidative c-Jun N-terminal kinase (JNK) activation was involved in the increased apoptosis levels but not the cell cycle arrest. CCRT also induced an increase in ceramide accompanied by a decrease in glucosylceramide that was positively correlated with the cytotoxic effects. Pharmacologically inhibiting glucosylceramide synthase facilitated VNR- and CCRT-induced apoptosis by promoting the JNK pathway. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of VNR by promoting JNK-mediated apoptosis in lung adenocarcinoma cells.

KW - CCRT

KW - Ceramide

KW - JNK

KW - NSCLC

KW - Vinorelbine

UR - http://www.scopus.com/inward/record.url?scp=84901434753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901434753&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2014.04.005

DO - 10.1016/j.canlet.2014.04.005

M3 - Article

C2 - 24735752

AN - SCOPUS:84901434753

VL - 349

SP - 144

EP - 151

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -